NAV
205.73
as on 29 Sep 23
3.37 (1.7%)
Last Change
14.3%
3Y CAGR returns
500
Min SIP
5,000
Min Lumpsum
1.39 %
Expense Ratio
Rating
776
Fund Size (in Cr)
11 Years
Fund Age
Mutual Fund SIP Calculator
Monthly Investment
Max: ₹1,00,000
Investment Period
Yrs
Max: 5 yrs
-
Invested Amount--
-
Wealth Gained--
-
Expected Amount--
Scheme Performance
1Y | 1Y | 3Y | 3Y | 5Y | 5Y | Max | Max | |
---|---|---|---|---|---|---|---|---|
Trailing Returns | 25.9% | 14.3% | 17% | 14.6% | ||||
Category Average | 23.8% | 13.8% | 14.4% | - |
Scheme Allocation
By Holding
By Sector
By Asset
12.6%
8.91%
7.13%
5.89%
5.34%
Others
View all Holdings
Holdings | Sector | Instrument | Asset |
---|---|---|---|
Sun Pharma.Inds. | Pharmaceuticals | Equity | 12.6% |
Cipla | Pharmaceuticals | Equity | 8.91% |
Dr Reddy's Labs | Pharmaceuticals | Equity | 7.13% |
Apollo Hospitals | Healthcare | Equity | 5.89% |
Ajanta Pharma | Pharmaceuticals | Equity | 5.34% |
Fortis Health. | Healthcare | Equity | 4.34% |
Aurobindo Pharma | Pharmaceuticals | Equity | 4.31% |
Krishna Institu. | Healthcare | Equity | 4.12% |
Divi's Lab. | Pharmaceuticals | Equity | 3.52% |
ERIS Lifescience | Pharmaceuticals | Equity | 3.21% |
Suven Pharma | Pharmaceuticals | Equity | 3.2% |
Torrent Pharma. | Pharmaceuticals | Equity | 3.09% |
Ipca Labs. | Pharmaceuticals | Equity | 2.93% |
Zydus Lifesci. | Pharmaceuticals | Equity | 2.74% |
Gland Pharma | Pharmaceuticals | Equity | 2.69% |
P & G Health Ltd | Pharmaceuticals | Equity | 2.14% |
Metropolis Healt | Healthcare | Equity | 2.07% |
Alkem Lab | Pharmaceuticals | Equity | 2.02% |
Concord Biotech | Pharmaceuticals | Equity | 1.94% |
Ami Organics | Pharmaceuticals | Equity | 1.7% |
Poly Medicure | Healthcare | Equity | 1.6% |
Syngene Intl. | Pharmaceuticals | Equity | 1.47% |
Biocon | Pharmaceuticals | Equity | 1.43% |
Mankind Pharma | Trading | Equity | 1.29% |
Alembic Pharma | Pharmaceuticals | Equity | 1.2% |
Abbott India | Pharmaceuticals | Equity | 1.19% |
Indoco Remedies | Pharmaceuticals | Equity | 1.12% |
Rainbow Child. | Healthcare | Equity | 1.09% |
Windlas Biotech | Pharmaceuticals | Equity | 1.04% |
Pfizer | Pharmaceuticals | Equity | 1.01% |
Sequent Scien. | Pharmaceuticals | Equity | 0.74% |
Star Health Insu | Insurance | Equity | 0.66% |
J B Chem & Pharm | Pharmaceuticals | Equity | 0.44% |
Pharmaceuticals & Biotech
76.21%
Healthcare Services
19.19%
Cash & Others
1.93%
Healthcare Equipment & Su
1.86%
Insurance
0.65%
Others
View all Sectors
Sectors | Asset |
---|---|
Pharmaceuticals & Biotech | 76.21% |
Healthcare Services | 19.19% |
Cash & Others | 1.93% |
Healthcare Equipment & Su | 1.86% |
Insurance | 0.65% |
Debt | 0.16% |
Others | 0.01% |
Equity
98.17%
Net Curr Ass/Net Receivables
1.66%
T-Bills
0.16%
Fixed Deposit
0.01%
Advance Ratio
1.12
Alpha
4.34
SD
0.94
Beta
1.06
Sharpe
Exit Load
Exit Load | 1.00% - If redeemed / switched out less than one year from the date of allotment. Nil - If redeemed / switched out greater than or equal to one year from the date of allotment. |
---|
Fund Objective
The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.
Fund Managers
Kamal Gada
Risk-O-Meter
Peer Comparison
Fund Name
- Fund Name
- Fund Size
- 1Y
- 3Y Returns
- 5Y
-
ICICI Pru Infrastructure Fund – Direct Growth- Equity .
- Sectoral / Thematic .
-
- 2,986
-
41.9%Fund Size - 2,986
-
46.7%Fund Size - 2,986
-
22.3%Fund Size - 2,986
-
Franklin Build India Fund – Direct Growth- Equity .
- Sectoral / Thematic .
-
- 1,506
-
42.7%Fund Size - 1,506
-
42.9%Fund Size - 1,506
-
20.7%Fund Size - 1,506
-
LIC MF Infrastructure Fund – Direct Growth- Equity .
- Sectoral / Thematic .
-
- 116
-
30.4%Fund Size - 116
-
36.1%Fund Size - 116
-
19.8%Fund Size - 116
-
Franklin India Opportunities Fund – Direct Growth- Equity .
- Sectoral / Thematic .
-
- 1,177
-
35.9%Fund Size - 1,177
-
30.2%Fund Size - 1,177
-
18.4%Fund Size - 1,177
-
ICICI Pru Banking & Financial Services – Dir Growth- Equity .
- Sectoral / Thematic .
-
- 6,740
-
21.1%Fund Size - 6,740
-
27.5%Fund Size - 6,740
-
13.9%Fund Size - 6,740
AMC Contact Details
UTI Mutual Fund
AUM:
2,48,191 Cr
Address:
UTI Towers, Gn Block,
Bandra Kurla Complex,
Bandra (East), Mumbai 400 051
Contact:
66786666
Email ID:
service@uti.co.in
Frequently Asked Questions
How to invest in UTI-Healthcare Fund – Direct Growth ?
You can invest in UTI-Healthcare Fund – Direct Growth in a quick and simple process. Follow the below steps;
- Login to your 5paisa account, Go to the Mutual Funds section.
- Search for UTI-Healthcare Fund – Direct Growth in the search box.
- Click on "Start SIP" if you wish to do a SIP or click on “One-time” if you wish to invest a lumpsum amount then click on "Invest Now"
What is the NAV of UTI-Healthcare Fund – Direct Growth ?
The NAV of UTI-Healthcare Fund – Direct Growth is ₹205.7 as of 29 September 2023.
How to redeem UTI-Healthcare Fund – Direct Growth holding ?
You can go to your holding on the app and click on the fund name you will get two options Invest More and Redeem; click on redeem and enter the amount or units you desire to redeem or you can tick on “Redeem all units”.
What is the minimum sip amount of UTI-Healthcare Fund – Direct Growth?
The minimum SIP amount of UTI-Healthcare Fund – Direct Growth is ₹500
What are the top sectors UTI-Healthcare Fund – Direct Growth has invested in?
The top sectors UTI-Healthcare Fund – Direct Growth has invested in are
- Pharmaceuticals & Biotech - 76.21%
- Healthcare Services - 19.19%
- Cash & Others - 1.93%
- Healthcare Equipment & Su - 1.86%
- Insurance - 0.65%
Can I make investments in both the SIP and Lump Sum schemes of UTI-Healthcare Fund – Direct Growth?
Yes, You can select both SIP or Lumpsum investment of UTI-Healthcare Fund – Direct Growth based on your investment objective and risk tolerance.
How much returns have UTI-Healthcare Fund – Direct Growth generated ?
The UTI-Healthcare Fund – Direct Growth has delivered 14.6% since inception
What is the expense ratio of UTI-Healthcare Fund – Direct Growth ?
The expense ratio of UTI-Healthcare Fund – Direct Growth is 1.39 % as of 29 September 2023.
What is the AUM of UTI-Healthcare Fund – Direct Growth?
The AUM of UTI-Healthcare Fund – Direct Growth is ₹2,48,191 Cr as of 29 September 2023
What are the top stock holdings of UTI-Healthcare Fund – Direct Growth?
The top stock holdings of UTI-Healthcare Fund – Direct Growth are
- Sun Pharma.Inds. - 12.6%
- Cipla - 8.91%
- Dr Reddy's Labs - 7.13%
- Apollo Hospitals - 5.89%
- Ajanta Pharma - 5.34%
How can I redeem my investments in UTI-Healthcare Fund – Direct Growth?
Step 1: Visit the fund house's website
Step 2: Log in to your account by adding Folio No. and M-Pin
Step 3: Click on Widhrawal > Redemption
Step 4: Select UTI-Healthcare Fund – Direct Growth in Scheme, enter the redemption amount, and click on submit button.
Step 2: Log in to your account by adding Folio No. and M-Pin
Step 3: Click on Widhrawal > Redemption
Step 4: Select UTI-Healthcare Fund – Direct Growth in Scheme, enter the redemption amount, and click on submit button.